Mizuho Securities USA LLC Has $1.92 Million Stake in STERIS plc (NYSE:STE)

Mizuho Securities USA LLC raised its holdings in STERIS plc (NYSE:STE) by 46.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 9,355 shares of the medical equipment provider’s stock after buying an additional 2,960 shares during the quarter. Mizuho Securities USA LLC’s holdings in STERIS were worth $1,923,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Avalon Trust Co bought a new stake in STERIS in the fourth quarter valued at about $30,000. Human Investing LLC acquired a new stake in STERIS during the fourth quarter valued at approximately $31,000. Anfield Capital Management LLC grew its stake in shares of STERIS by 100.0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock valued at $37,000 after purchasing an additional 91 shares during the period. Central Pacific Bank Trust Division raised its holdings in shares of STERIS by 65.5% in the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after buying an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC lifted its position in shares of STERIS by 182.7% during the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after buying an additional 137 shares during the period. Institutional investors and hedge funds own 94.69% of the company’s stock.

Wall Street Analysts Forecast Growth

STE has been the subject of several recent analyst reports. Stephens reiterated an “overweight” rating and set a $240.00 price objective on shares of STERIS in a research note on Thursday, February 6th. Piper Sandler lifted their price target on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a research note on Thursday, February 6th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $258.75.

STERIS Stock Performance

STERIS stock opened at $223.03 on Tuesday. The stock has a 50-day simple moving average of $221.34 and a 200 day simple moving average of $221.73. The stock has a market capitalization of $21.91 billion, a price-to-earnings ratio of 47.35 and a beta of 0.92. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. STERIS plc has a 12-month low of $197.82 and a 12-month high of $248.24.

STERIS (NYSE:STE) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, research analysts anticipate that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were given a $0.57 dividend. The ex-dividend date was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.02%. STERIS’s payout ratio is 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.